Table1 Optimization study.
From: Diarylation of thiazolopyrimidines by laccase and their in vitro evaluation as antitumor agents
Entrya | Enzyme (ml) | Buffer | Co-solvent | Time(h) | Yieldb (%) |
---|---|---|---|---|---|
1 | 0.5 | Phosphate buffer pH 8 (10 mM) | CH3CN | 4 | 23 |
2 | 1 | Phosphate buffer pH 8 (10 mM) | CH3CN | 4 | 65 |
3 | 2 | Phosphate buffer pH 8 (10 mM) | CH3CN | 4 | 63 |
4 | 0 | Phosphate buffer pH 8 (10 mM) | CH3CN | 24 | N.Rc |
5 | 1 | Phosphate buffer pH 8 (10 mM) | MeOH | 24 | N.R |
6 | 1 | Phosphate buffer pH 8 (10 mM | EtOH | 24 | N.R |
7 | 1 | Citrate buffer pH 3.5 (10 mM) | CH3CN | 24 | trace |
8 | 1 | Citrate buffer pH 3.5 (10 mM) | MeOH | 24 | N.R |
9 | 1 | Phosphate buffer pH 4.5 (10 mM) | MeOH | 24 | N.R |
10 | 1 | Phosphate buffer pH 7 (10 mM) | CH3CN | 24 | 8 |
11 | 1 | Phosphate buffer pH 4.5 (10 mM) | CH3CN | 24 | trace |